InflaRx (IFRX) Short Interest Ratio & Short Volume $1.73 -0.12 (-6.49%) Closing price 04:00 PM EasternExtended Trading$1.72 0.00 (-0.29%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock InflaRx Short Interest DataInflaRx (IFRX) has a short interest of 924,200 shares, representing 1.64% of the float (the number of shares available for trading by the public). This marks a 16.31% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 230,700 shares to cover all short positions.Current Short Interest924,200 sharesPrevious Short Interest794,600 sharesChange Vs. Previous Month+16.31%Dollar Volume Sold Short$1.02 millionShort Interest Ratio2.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares67,133,000 sharesShort Percent of Float1.64%Today's Trading Volume325,163 sharesAverage Trading Volume230,700 sharesToday's Volume Vs. Average141% Short Selling InflaRx? Sign up to receive the latest short interest report for InflaRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIFRX Short Interest Over TimeIFRX Days to Cover Over TimeIFRX Percentage of Float Shorted Over Time InflaRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025924,200 shares $1.02 million +16.3%1.6%2.3 $1.10 3/31/2025794,600 shares $810,492.00 +36.8%1.4%2 $1.02 3/15/2025581,000 shares $691,390.00 +2.9%1.0%1.7 $1.19 2/28/2025564,700 shares $784,933.00 +46.2%1.0%1.5 $1.39 2/15/2025386,300 shares $772,600.00 -7.0%0.7%1 $2.00 1/31/2025415,200 shares $1.00 million -13.7%N/A1.4 $2.41 1/15/2025481,300 shares $1.21 million +93.4%N/A1.8 $2.52 12/31/2024248,900 shares $614,783.00 +15.0%N/A0.9 $2.47 12/15/2024216,500 shares $510,940.00 +37.9%N/A0.9 $2.36 11/30/2024157,000 shares $386,220.00 -3.4%N/A0.8 $2.46 Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024162,600 shares $317,070.00 -3.2%N/A1 $1.95 10/31/2024168,000 shares $260,400.00 -30.5%N/A2.3 $1.55 10/15/2024241,700 shares $357,716.00 -8.1%N/A3.4 $1.48 9/30/2024262,900 shares $402,237.00 +63.2%N/A4.4 $1.53 9/15/2024161,100 shares $230,373.00 -26.6%N/A2.3 $1.43 8/31/2024219,400 shares $348,846.00 -3.6%N/A3.1 $1.59 8/15/2024227,600 shares $307,260.00 -9.2%N/A2.3 $1.35 7/31/2024250,600 shares $375,900.00 +281.4%N/A1.9 $1.50 7/15/202465,700 shares $109,062.00 -71.8%N/A0.5 $1.66 6/30/2024232,800 shares $405,072.00 +151.1%N/A1.3 $1.74 6/15/202492,700 shares $144,612.00 +233.5%N/A0.5 $1.56 5/31/202427,800 shares $39,754.00 -61.3%N/A0.1 $1.43 5/15/202471,800 shares $100,520.00 -45.4%N/A0.3 $1.40 4/30/2024131,500 shares $180,155.00 +2.9%N/A0.6 $1.37 4/15/2024127,800 shares $177,642.00 -67.2%N/A0.6 $1.39 3/31/2024389,100 shares $599,214.00 +22.9%N/A1.7 $1.54 3/15/2024316,700 shares $500,386.00 +7.8%N/A1.2 $1.58 2/29/2024293,900 shares $523,142.00 -9.4%N/A1.1 $1.78 2/15/2024324,200 shares $499,268.00 +5.6%N/A1.2 $1.54 1/31/2024307,000 shares $497,340.00 -19.5%N/A1.2 $1.62 1/15/2024381,200 shares $659,476.00 -18.2%N/A0.9 $1.73 12/31/2023466,200 shares $759,906.00 -26.1%N/A1.1 $1.63 12/15/2023631,200 shares $826,872.00 -7.9%N/A1.7 $1.31 11/30/2023685,300 shares $925,155.00 +1.9%N/A2.1 $1.35 11/15/2023672,500 shares $975,125.00 +298.9%N/A2.1 $1.45 10/31/2023168,600 shares $284,934.00 +81.5%N/A0.5 $1.69 10/15/202392,900 shares $217,386.00 -10.8%N/A0.5 $2.34 9/30/2023104,200 shares $310,516.00 -46.1%N/A0.6 $2.98 9/15/2023193,300 shares $730,674.00 +2.8%N/A1.1 $3.78 8/31/2023188,100 shares $742,995.00 -33.1%N/A0.9 $3.95Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 8/15/2023281,300 shares $970,485.00 -12.2%N/A1.2 $3.45 7/31/2023320,300 shares $1.34 million +5.3%N/A1.3 $4.19 7/15/2023304,100 shares $1.26 million -15.2%N/A1 $4.15 6/30/2023358,700 shares $1.60 million -44.7%N/A0.5 $4.46 6/15/2023648,500 shares $2.89 million -14.9%N/A0.3 $4.45 5/31/2023761,900 shares $3.19 million +8.0%N/A0.3 $4.19 5/15/2023705,400 shares $3.41 million -26.3%N/A0.3 $4.84 4/30/2023956,900 shares $4.66 million -49.4%2.5%0.4 $4.87 4/15/20231,890,000 shares $8.18 million +933.4%5.0%0.8 $4.33 3/31/2023182,900 shares $354,826.00 -10.3%0.5%0.1 $1.94 3/15/2023203,900 shares $364,981.00 -12.5%0.5%2.1 $1.79 2/28/2023233,000 shares $450,855.00 -2.2%0.6%2.3 $1.94 2/15/2023238,200 shares $521,658.00 -10.6%0.6%2.3 $2.19 1/31/2023266,400 shares $578,088.00 -12.4%0.7%2.5 $2.17 1/15/2023304,100 shares $799,783.00 -12.6%0.8%2.9 $2.63 12/30/2022348,000 shares $1.08 million -1.7%0.9%3.3 $3.10 12/15/2022354,100 shares $789,643.00 -14.8%0.9%3.5 $2.23 11/30/2022415,800 shares $1.08 million -0.5%1.1%4.5 $2.60 11/15/2022417,900 shares $1.07 million +2.1%1.1%4.3 $2.57 10/31/2022409,200 shares $1.06 million -4.1%1.1%3.5 $2.60 10/15/2022426,800 shares $1.02 million -0.4%1.1%1.2 $2.39 9/30/2022428,700 shares $1.13 million +1.4%1.1%1.2 $2.64 9/15/2022422,800 shares $1.18 million -5.4%1.1%0.7 $2.78 8/31/2022447,100 shares $988,091.00 +6.9%1.2%0.8 $2.21 8/15/2022418,300 shares $1.13 million -52.4%1.1%0.7 $2.71 7/31/2022878,400 shares $2.41 million +7.9%2.3%1.6 $2.74 7/15/2022813,800 shares $1.10 million -6.7%2.2%1.8 $1.35 6/30/2022872,400 shares $1.26 million +511.4%2.3%2.5 $1.45 6/15/2022142,700 shares $181,229.00 +9.0%0.4%0.8 $1.27 5/31/2022130,900 shares $208,131.00 +35.8%0.4%0.6 $1.59 5/15/202296,400 shares $140,744.00 -32.0%0.3%0.4 $1.46 4/30/2022141,700 shares $239,473.00 -30.9%0.4%0.6 $1.69 4/15/2022205,100 shares $369,180.00 -43.2%0.6%0.8 $1.80 3/31/2022361,000 shares $660,630.00 -30.6%N/A1.3 $1.83 3/15/2022520,500 shares $1.09 million -18.8%1.5%2.2 $2.09 2/28/2022640,600 shares $1.70 million -12.6%1.8%2.8 $2.66 2/15/2022732,500 shares $2.53 million -8.3%2.1%2.4 $3.45 1/31/2022798,400 shares $2.85 million -11.1%2.2%1.6 $3.57 1/15/2022898,500 shares $3.82 million -4.7%N/A0 $4.25 12/31/2021943,100 shares $4.49 million -17.3%2.6%0.3 $4.76 12/15/20211,140,000 shares $4.71 million +1.8%3.1%0.4 $4.13 11/30/20211,120,000 shares $5.61 million +68.0%3.1%0.4 $5.01 11/15/2021666,800 shares $3.27 million -23.2%1.8%0.2 $4.90 10/29/2021868,200 shares $3.68 million +116.0%2.4%0.3 $4.24 10/15/2021401,900 shares $992,693.00 +27.4%1.1%0.7 $2.47 9/30/2021315,500 shares $817,145.00 -13.4%0.9%1.1 $2.59 9/15/2021364,500 shares $1.01 million +212.1%1.0%1.5 $2.76 8/31/2021116,800 shares $300,176.00 -12.9%0.3%0.5 $2.57 8/13/2021134,100 shares $323,181.00 +64.3%0.4%0.8 $2.41 7/30/202181,600 shares $212,160.00 +91.6%0.2%0.4 $2.60Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 7/15/202142,600 shares $109,482.00 +41.1%0.1%0.2 $2.57 6/30/202130,200 shares $89,694.00 -14.5%0.1%0.1 $2.97 6/15/202135,300 shares $110,489.00 -26.3%0.1%0.1 $3.13 5/28/202147,900 shares $146,095.00 -69.8%0.1%0.2 $3.05 5/14/2021158,600 shares $431,392.00 +100.5%N/A0.4 $2.72 4/30/202179,100 shares $295,834.00 -86.8%N/A0.2 $3.74 4/15/2021598,100 shares $2.26 million +12.0%3.1%1.6 $3.78 3/31/2021533,900 shares $2.02 million +3.6%2.7%1.3 $3.79 3/15/2021515,200 shares $2.47 million +19.8%2.7%1.3 $4.79 2/26/2021430,000 shares $1.93 million -8.0%2.2%1 $4.49 2/12/2021467,200 shares $2.70 million +1.3%2.4%1.4 $5.77 1/29/2021461,200 shares $2.56 million +5.2%2.4%1.5 $5.54 1/15/2021438,600 shares $2.64 million +6.1%2.3%1.5 $6.03 12/31/2020413,300 shares $2.03 million -37.7%2.1%1.5 $4.91 12/15/2020663,100 shares $3.30 million +34.8%3.4%1.9 $4.98 11/30/2020492,100 shares $1.96 million +2.4%2.5%1.4 $3.98 11/15/2020480,800 shares $2.02 million -4.4%2.5%1.4 $4.20 10/30/2020503,100 shares $2.07 million -15.1%2.6%1.4 $4.12 10/15/2020592,600 shares $2.99 million +27.4%3.1%1.4 $5.05 9/30/2020465,300 shares $1.98 million +20.1%2.4%0.7 $4.26 9/15/2020387,500 shares $1.86 million -5.6%1.9%0.7 $4.80 8/31/2020410,600 shares $1.81 million -40.2%2.1%0.6 $4.40 8/14/2020686,200 shares $3.01 million -26.4%3.4%0.9 $4.38 7/31/2020932,500 shares $4.68 million +30.3%5.4%1 $5.02 7/15/2020715,700 shares $3.52 million +4.5%4.1%0.7 $4.92 6/30/2020684,800 shares $3.31 million +40.3%4.0%0.8 $4.83 6/15/2020488,000 shares $3.27 million +235.2%2.8%0.3 $6.70 5/29/2020145,600 shares $1.30 million -62.7%0.8%0.1 $8.96 5/15/2020390,600 shares $2.85 million -54.9%2.3%0.3 $7.29 IFRX Short Interest - Frequently Asked Questions What is InflaRx's current short interest? Short interest is the volume of InflaRx shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 924,200 shares of IFRX short. 1.64% of InflaRx's shares are currently sold short. Learn More on InflaRx's current short interest. What is a good short interest ratio for InflaRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IFRX shares currently have a short interest ratio of 2.0. Learn More on InflaRx's short interest ratio. Which institutional investors are shorting InflaRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of InflaRx: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for InflaRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.64% of InflaRx's floating shares are currently sold short. Is InflaRx's short interest increasing or decreasing? InflaRx saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 924,200 shares, an increase of 16.3% from the previous total of 794,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InflaRx's short interest compare to its competitors? 1.64% of InflaRx's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InflaRx: Benitec Biopharma Inc. (1.24%), Cartesian Therapeutics, Inc. (28.47%), Monte Rosa Therapeutics, Inc. (16.37%), ProKidney Corp. (14.50%), Atai Life Sciences (8.91%), Atyr PHARMA INC (11.66%), Phathom Pharmaceuticals, Inc. (21.93%), Cryoport, Inc. (5.39%), Astria Therapeutics, Inc. (6.79%), Aquestive Therapeutics, Inc. (11.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short InflaRx stock? Short selling IFRX is an investing strategy that aims to generate trading profit from InflaRx as its price is falling. IFRX shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InflaRx? A short squeeze for InflaRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IFRX, which in turn drives the price of the stock up even further. How often is InflaRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IFRX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Benitec Biopharma Short Squeeze Cartesian Therapeutics Short Squeeze Monte Rosa Therapeutics Short Squeeze ProKidney Short Squeeze Atai Life Sciences Short Squeeze Atyr PHARMA Short Squeeze Phathom Pharmaceuticals Short Squeeze Cryoport Short Squeeze Astria Therapeutics Short Squeeze Aquestive Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IFRX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx Please log in to your account or sign up in order to add this asset to your watchlist. Share InflaRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IFRX Stock Free IFRX Stock Alerts